Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | EO1428 | 1.0 | uM | 1 | TNF-a | 23.0 | 75 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | TNF-a | 4439.0 | 72 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | TNF-a | 5286.0 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | TNF-a | 5989.0 | 72 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | TNF-a | 5546.0 | 68 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | TNF-a | 5974.5 | 46 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | TNF-a | 4756.5 | 56 | |
N2586 | EO1428 | 1.0 | uM | 1 | TNF-a | 23.5 | 40 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 38.0 | 78 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 32.5 | 64 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 24.5 | 78 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 39.5 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 42.0 | 64 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 19.5 | 80 | |
RA2159 | PI103 | 0.1 | uM | 1 | TNF-a | 20.0 | 72 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 39.0 | 79 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 32.5 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 35.5 | 76 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 41.5 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 41.0 | 73 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | TNF-a | 27.0 | 59 | |
N2586 | PI103 | 0.1 | uM | 1 | TNF-a | 20.0 | 72 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | TNF-a | 28.0 | 58 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | TNF-a | 24.0 | 87 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNF-a | 22.5 | 82 |